Shmuel Shoham, MD - Do You Know How to Use COVID-19 Monoclonal Antibodies as Pre-Exposure Prophylaxis for Your Post-Transplant Patients? Test Your Knowledge

Go online to PeerView.com/EWZ860 to view the activity, download
slides and practice aids, and complete the post-test to earn
credit. Solid organ transplant recipients may be at increased risk
for COVID-19 because they are immunosuppressed and less likely to
mount effective immune responses to vaccination. In this
educational symposium based on a live event, a panel of expert
faculty address the identification of transplant patients who would
likely derive benefit from anti-SARS-CoV-2 monoclonal antibodies
(mAbs) and strategies that can be used to overcome barriers to
COVID-19 pre-exposure prophylaxis access. In addition, they provide
guidance on mAb qualities and clinical profiles and shared
decision-making strategies to customize mAb pre-exposure
prophylaxis at the point of care for transplant recipients needing
protection against COVID-19. After participating in this activity,
the learner will demonstrate the ability to: Identify
post-transplant patients who would likely derive benefit from
pre-exposure prophylaxis with anti-SARS-CoV-2 monoclonal antibodies
(mAbs); Use strategies to overcome barriers to COVID-19
pre-exposure prophylaxis access for post-transplant patients; and
Incorporate evidence-based recommendations and guidelines, mAb
qualities and clinical profiles, and shared decision-making into
strategies to customize mAb pre-exposure prophylaxis at point of
care for post-transplant patients needing protection against
COVID-19.